The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(2'R,3S,4'S)-6-chloro-4'-(3-chloro-2-fluorophenyl)-N-((1s,3R)-3-hydroxy-3-methylcyclobutyl)-2'-neopentyl-2-oxospiro[indoline-3,3'-pyrrolidine]-5'-carboxamide ID: ALA4537250
PubChem CID: 155548608
Max Phase: Preclinical
Molecular Formula: C28H32Cl2FN3O3
Molecular Weight: 548.49
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CC(C)(C)C[C@H]1NC(C(=O)N[C@H]2C[C@@](C)(O)C2)[C@H](c2cccc(Cl)c2F)[C@@]12C(=O)Nc1cc(Cl)ccc12
Standard InChI: InChI=1S/C28H32Cl2FN3O3/c1-26(2,3)13-20-28(17-9-8-14(29)10-19(17)33-25(28)36)21(16-6-5-7-18(30)22(16)31)23(34-20)24(35)32-15-11-27(4,37)12-15/h5-10,15,20-21,23,34,37H,11-13H2,1-4H3,(H,32,35)(H,33,36)/t15-,20-,21+,23?,27+,28+/m1/s1
Standard InChI Key: MZBOZBMARIQZGX-OZSDUJMASA-N
Molfile:
RDKit 2D
37 41 0 0 0 0 0 0 0 0999 V2000
29.4375 -8.2292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.8542 -8.8167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.6546 -9.0281 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
26.9781 -11.0307 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.6584 -10.5590 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.4201 -9.7661 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
26.5917 -9.7479 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.3191 -10.5301 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.3917 -12.3042 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.6484 -11.5200 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.3566 -8.9571 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.9239 -8.3581 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.5542 -8.7653 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
27.7263 -8.5499 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.4372 -10.8312 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.0624 -10.2929 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.8412 -10.5652 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.9087 -9.4824 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.6417 -9.7042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.4336 -11.2669 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
25.5117 -10.3662 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.2505 -9.5825 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.4428 -9.4182 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.8955 -10.0368 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.1616 -10.8222 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.9686 -10.9828 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.5667 -12.3042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.3145 -11.5211 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.5118 -11.3493 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.9605 -11.9597 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.2174 -12.7445 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.0195 -12.9126 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.6670 -13.3590 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
23.6174 -11.4423 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
24.5500 -11.6917 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
28.1545 -9.2499 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.4257 -8.1151 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
2 3 1 1
4 5 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 4 1 0
27 9 1 0
9 10 1 0
10 4 1 0
4 28 1 1
7 11 1 0
11 12 1 0
11 13 2 0
14 12 1 1
5 15 1 6
15 16 1 0
16 17 1 0
16 18 1 0
16 19 1 0
10 20 2 0
21 22 2 0
22 23 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 21 1 0
8 21 1 1
27 28 2 0
28 29 1 0
29 30 2 0
30 31 1 0
31 32 2 0
32 27 1 0
31 33 1 0
25 34 1 0
26 35 1 0
14 36 1 0
36 2 1 0
2 37 1 0
37 14 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 548.49Molecular Weight (Monoisotopic): 547.1805AlogP: 4.91#Rotatable Bonds: 4Polar Surface Area: 90.46Molecular Species: BASEHBA: 4HBD: 4#RO5 Violations: 1HBA (Lipinski): 6HBD (Lipinski): 4#RO5 Violations (Lipinski): 1CX Acidic pKa: 12.88CX Basic pKa: 8.99CX LogP: 4.33CX LogD: 2.74Aromatic Rings: 2Heavy Atoms: 37QED Weighted: 0.44Np Likeness Score: -0.15
References 1. Liu Y, Wang X, Wang G, Yang Y, Yuan Y, Ouyang L.. (2019) The past, present and future of potential small-molecule drugs targeting p53-MDM2/MDMX for cancer therapy., 176 [PMID:31100649 ] [10.1016/j.ejmech.2019.05.018 ]